Nicodrops, Inc. (NCDP)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nicodrops, Inc. (NCDP) trades at $0.00 with AI Score 46/100 (Grade C). Nicodrops, Inc. develops and provides drug-free, non-nicotine smoking alternatives in the form of herbal dietary supplements. Market cap: $1,848, Sector: Consumer defensive.
Last analyzed: Mar 18, 2026Analyst Coverage for NCDP: NCDP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NCDP against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NCDP: the 1 perspectives are evenly split.
Nicodrops, Inc. (NCDP) Consumer Business Overview
Nicodrops, Inc. operates within the consumer defensive sector, focusing on herbal dietary supplements designed as smoking alternatives. Their lozenge-based product aims to reduce stress related to quitting smoking, positioning them within the niche market of non-nicotine smoking cessation aids, competing with established brands in the health and wellness space.
What Is the Investment Thesis for NCDP?
Nicodrops, Inc. presents a speculative investment opportunity within the consumer defensive sector, specifically targeting the smoking cessation market. The company's herbal dietary supplement offers a potential alternative to traditional nicotine replacement therapies, appealing to consumers seeking drug-free options. However, with a market capitalization of $0.00B and a high beta of 102.02, NCDP exhibits significant volatility and risk. Growth catalysts include increasing consumer awareness of the health risks associated with smoking and a growing demand for natural smoking cessation aids. The company's ability to secure distribution agreements with major retailers and demonstrate the efficacy of its product will be crucial for driving revenue growth. Key risks include competition from established pharmaceutical companies, regulatory hurdles related to dietary supplements, and the company's limited financial resources. Investors should carefully consider the speculative nature of this investment and the potential for significant losses.
Based on FMP financials and quantitative analysis
NCDP Key Highlights
- Nicodrops, Inc. operates in the consumer defensive sector, providing herbal dietary supplements.
- The company's primary product is a cough drop form designed to reduce stress associated with quitting smoking.
- Nicodrops, Inc. is based in San Diego, California, focusing on the United States market.
- The company faces competition from established pharmaceutical and consumer goods companies.
- Market Cap is $0.00B, indicating a micro-cap company.
Who Are NCDP's Competitors?
NCDP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| FACYF Fancl Corporation | $17.45 | +0.00% | $2.37B | 63 |
| SGI Somnigroup International Inc | $72.67 | +0.48% | $15.28B | 62 |
| ELF e.l.f. Beauty, Inc. | $60.68 | +4.40% | $3.61B | 59 |
| MIOFF Milbon Co., Ltd. | $52.60 | +0.00% | $1.71B | 58 |
| KCDMF Kimberly-Clark de México, S. A. B. de C. V. | $2.10 | -3.67% | $6.30B | 48 |
| PG The Procter & Gamble Company | $148.32 | -0.49% | $345.38B | 48 |
| KCDMY Kimberly-Clark de México, S. A. B. de C. V. | $10.66 | +4.00% | $6.41B | 48 |
| RBGLY Reckitt Benckiser Group plc | $12.56 | -0.24% | $39.94B | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NCDP's Key Strengths?
- Drug-free, herbal-based formulation.
- Focus on a specific niche market (smoking cessation).
- Potential for strong brand recognition.
- Proprietary lozenge formula.
What Are NCDP's Weaknesses?
- Limited financial resources.
- Small market share.
- Dependence on a single product.
- Lack of clinical trial data.
What Could Drive NCDP Stock Higher?
- Potential partnerships with retailers to expand distribution channels.
- Launch of new herbal supplement formulations targeting specific smoking cessation needs.
- Increasing consumer awareness of the health risks associated with smoking.
- Growing demand for natural and drug-free smoking cessation aids.
What Are the Key Risks for NCDP?
- Competition from established pharmaceutical companies with greater resources.
- Regulatory changes impacting the dietary supplement industry.
- Limited financial resources and market share.
- Dependence on a single product for revenue generation.
- Negative publicity or product recalls.
What Are the Growth Opportunities for NCDP?
- Expansion of Product Line: Nicodrops, Inc. can expand its product line to include other herbal supplements and formulations targeting different aspects of smoking cessation, such as cravings and withdrawal symptoms. The market for smoking cessation aids is estimated to be worth billions of dollars annually, providing ample opportunity for growth. By introducing new products, Nicodrops can attract a wider range of customers and increase its market share. This expansion could be realized within the next 2-3 years with sufficient investment in research and development.
- Strategic Partnerships: Forming strategic partnerships with retailers, pharmacies, and healthcare providers can significantly expand Nicodrops' distribution network and reach a larger customer base. Collaborating with established players in the health and wellness industry can also enhance the company's credibility and brand recognition. The timeline for establishing these partnerships is approximately 1-2 years, depending on the company's ability to negotiate favorable terms and demonstrate the value of its product.
- Online Sales and Marketing: Investing in online sales and marketing efforts can enable Nicodrops to reach a global audience and bypass traditional distribution channels. E-commerce platforms and social media marketing can be used to promote the company's products and engage with potential customers. The online market for health and wellness products is growing rapidly, offering a significant opportunity for Nicodrops to increase its sales and brand awareness. This initiative can be implemented within the next 6-12 months.
- International Expansion: Expanding into international markets can provide Nicodrops with access to new customer segments and revenue streams. Countries with high smoking rates and a growing interest in natural health products represent attractive opportunities for expansion. However, international expansion requires careful planning and consideration of regulatory requirements and cultural differences. The timeline for international expansion is approximately 3-5 years, depending on the company's resources and strategic priorities.
- Clinical Trials and Research: Conducting clinical trials and research to demonstrate the efficacy of Nicodrops' herbal supplement can enhance its credibility and attract more customers. Scientific evidence supporting the product's benefits can also be used to differentiate it from competitors and gain regulatory approvals. Investing in research and development is essential for building a strong foundation for long-term growth. Clinical trials could be initiated within the next 1-2 years, with results expected within 2-3 years.
What Opportunities Does NCDP Have?
- Expansion of product line.
- Strategic partnerships with retailers.
- Online sales and marketing.
- International expansion.
What Threats Does NCDP Face?
- Competition from established pharmaceutical companies.
- Regulatory hurdles related to dietary supplements.
- Changing consumer preferences.
- Economic downturn.
What Are NCDP's Competitive Advantages?
- Proprietary herbal formulation.
- Focus on drug-free smoking cessation.
- Brand recognition in the niche market of herbal smoking alternatives.
What Does NCDP Do?
Nicodrops, Inc., based in San Diego, California, develops and markets drug-free, non-nicotine smoking alternatives. The company's primary product is an herbal dietary supplement in cough drop form, formulated with natural herbal ingredients intended to alleviate the stress associated with quitting smoking. Founded to address the demand for non-addictive smoking cessation aids, Nicodrops aims to provide a healthier alternative to traditional nicotine replacement therapies. The company operates within the broader consumer defensive sector, specifically targeting individuals seeking to reduce or eliminate their dependence on nicotine. Their product is available in lozenge form, making it a discreet and accessible option for users. Nicodrops, Inc. focuses on the United States market, where it competes with a range of smoking cessation products, including nicotine patches, gums, and prescription medications. The company differentiates itself by offering a drug-free, herbal-based solution. Nicodrops, Inc. faces the challenge of establishing brand recognition and market share in a competitive landscape dominated by larger pharmaceutical and consumer goods companies. Their success depends on effective marketing, distribution, and demonstrating the efficacy of their herbal supplement in reducing smoking-related stress. The company's long-term growth strategy involves expanding its product line and distribution channels, potentially including online sales and partnerships with retailers specializing in health and wellness products.
What Products and Services Does NCDP Offer?
- Develops drug-free, non-nicotine smoking alternatives.
- Offers herbal dietary supplements in the United States.
- Provides a cough drop form of herbal supplement.
- Formulates lozenges with natural herbal dietary ingredients.
- Aims to reduce the stress associated with not smoking.
- Markets its products to individuals seeking to quit smoking.
How Does NCDP Make Money?
- Develops and manufactures herbal dietary supplements.
- Markets and sells its products directly to consumers.
- Generates revenue through the sale of its cough drop lozenges.
What Industry Does NCDP Operate In?
Nicodrops, Inc. operates within the consumer defensive sector, specifically in the household and personal products industry. This sector is generally considered stable, as it provides essential goods and services that consumers continue to purchase regardless of economic conditions. The smoking cessation market is a subset of this industry, driven by increasing awareness of the health risks associated with smoking and a desire to quit. The market is competitive, with established players offering nicotine replacement therapies and prescription medications. Nicodrops aims to differentiate itself by offering a drug-free, herbal-based alternative.
Who Are NCDP's Key Customers?
- Individuals seeking to quit smoking.
- Consumers looking for drug-free smoking alternatives.
- People interested in herbal dietary supplements.
NCDP Latest News
No recent news available for NCDP.
NCDP Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NCDP.
Price Targets
Wall Street price target analysis for NCDP.
NCDP MoonshotScore
What does this score mean?
The MoonshotScore rates NCDP's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Christopher L. Calpito
CEO
Christopher L. Calpito serves as the Chief Executive Officer of Nicodrops, Inc. His background includes experience in the consumer goods and dietary supplement industries. He has a track record of developing and marketing innovative products. Prior to joining Nicodrops, Inc., Mr. Calpito held leadership positions at several companies focused on health and wellness. His expertise includes product development, marketing, and sales.
Track Record: Under Mr. Calpito's leadership, Nicodrops, Inc. has focused on developing and launching its herbal dietary supplement for smoking cessation. He has overseen the company's efforts to establish a brand presence in the competitive market and secure distribution channels. His strategic decisions have centered on product innovation and market expansion.
NCDP OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Nicodrops, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited or no financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud and scams.
- Limited regulatory oversight.
- Verify the company's registration and legal status.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Research the background and experience of the company's management team.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal proceedings against the company.
- Company has a registered business address.
- CEO is publicly known.
- Company has a website and online presence.
- The company's product is available for purchase.
- Positive customer reviews (if available).
Nicodrops, Inc. Consumer Defensive Stock: Key Questions Answered
What does Nicodrops, Inc. do?
Nicodrops, Inc. develops and markets drug-free, non-nicotine smoking alternatives in the form of herbal dietary supplements. The company's primary product is a cough drop lozenge formulated with natural herbal ingredients designed to reduce the stress associated with quitting smoking. Nicodrops targets individuals seeking to reduce or eliminate their dependence on nicotine by providing a healthier alternative to traditional nicotine replacement therapies. The company operates within the consumer defensive sector, specifically focusing on the smoking cessation market in the United States.
What are the main risks for NCDP?
The main risks for Nicodrops, Inc. include intense competition from established pharmaceutical companies with significantly greater resources, regulatory hurdles related to the dietary supplement industry, and the company's limited financial resources and market share. Dependence on a single product for revenue generation also poses a significant risk. Furthermore, as an OTC-listed company, NCDP faces additional risks related to liquidity, transparency, and potential price manipulation. The 'Shell Risk Detected' warning suggests heightened scrutiny is warranted.
What are the key factors to evaluate for NCDP?
Nicodrops, Inc. (NCDP) holds an AI score of 46/100 (low). Not financial advice.
How frequently does NCDP data refresh on this page?
NCDP prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NCDP's recent stock price performance?
Nicodrops, Inc. (NCDP) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Drug-free, herbal-based formulation. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NCDP overvalued or undervalued right now?
Valuing Nicodrops, Inc. (NCDP) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NCDP?
Before investing in Nicodrops, Inc. (NCDP), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NCDP to a portfolio?
Key strength of Nicodrops, Inc. (NCDP): Drug-free, herbal-based formulation. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC market data may be less reliable than exchange-listed data.
- AI analysis is pending and may provide further insights.